• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sakar Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 66415.0
  • ISIN : INE732S01012
342.90 -1 (-0.28%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    341.05

  • Today’s High

    348.90

  • Open

    341.05

  • Perv Close

    343.85

  • 52W Low

    210.10

  • 52W High

    380.80

Key Indicators

  • P/E(TTM)

    38.02

  • Mar.Cap (₹Cr.)

    752.66

  • Div & Yield %

    0.00

  • Book Value(₹)

    130.10

  • Debt-Equity Ratio

    -0.28

  • AGM Date

    01-Aug-2025

  • EPS

    9.02

  • P/E Ratio

    38.02

Financials Ratios

  • Debt-Equity Ratio

    0.46

  • Mar.Cap (₹Cr.)

    752.66

  • RONW (%)

    5.36

  • ROCE (%)

    7.36

Score Board

  • Equity (₹ in Cr.)

    21.95

  • BV (₹)

    130.10

  • Sales( ₹ in Cr.)

    177.58

  • NP (in Cr.)

    17.54

  • NP Var(%)

    52.0

  • Div%

    0.0

  • CPS (₹)

    17.50

  • EPS (₹)

    8.00

  • Traded Value (₹ in Lakhs)

    752.66

  • 52 Week High

    380.80

  • 52 Week Low

    210.10

  • Price BSE

    0.0

  • Price NSE

    343.00

  • Market Capital( in Cr.)

    752.66

  • P/C Ratio

    19.60

  • P/E Ratio

    42.90

  • Price Vs.BV

    8.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 153.35 133.36 128.23 94.74 82.98 68.25
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 153.35 133.36 128.23 94.74 82.98 68.25
Other Income 3.18 4.67 2.17 1.18 2.02 0.68
Stock Adjustments 1.38 0.36 -0.93 0.91 -0.15 -0.11
Total Income 157.91 138.39 129.47 96.83 84.85 68.82
EXPENDITURE :            
Raw Materials 85.05 74.00 73.69 52.20 43.00 35.57
Power and Fuel Cost 4.25 2.90 3.01 2.26 3.31 3.23
Employee Cost 18.82 15.81 14.26 12.74 11.61 8.45
Other Manufacturing Expenses 0.74 0.69 0.95 0.90 0.89 0.71
Selling and Administration Expenses 6.92 6.85 5.70 4.11 4.38 3.23
Miscellaneous Expenses 0.57 0.34 0.28 0.84 0.09 0.09
Employee Benefit Expenses 18.82 15.81 14.26 12.74 11.61 8.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 116.36 100.58 97.89 73.04 63.28 51.28
Operating Profit 41.54 37.81 31.58 23.78 21.57 17.54
Interest 7.59 5.95 2.90 2.48 2.26 2.27
Gross Profit 33.95 31.86 28.68 21.30 19.31 15.27
Depreciation 18.05 14.99 9.67 8.06 7.08 6.04
Profit Before Tax 15.90 16.87 19.01 13.24 12.23 9.23
Current Tax 0.00 0.00 3.41 3.18 2.63 2.59
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.23 4.12 0.35 -0.63 -0.03 -0.05
Reported Net Profit 11.67 12.76 15.24 10.69 9.62 6.69
Extraordinary Items 0.17 0.07 0.03 -0.11 -0.04 -0.04
Adjusted Net Profit 11.50 12.69 15.21 10.80 9.66 6.73
Adjustment below Net Profit 0.00 0.00 0.00 -0.75 0.00 -0.01
P & L Balance brought forward 68.95 56.19 40.95 31.00 21.38 14.69
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 80.62 68.95 56.19 40.95 31.00 21.38
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.37 6.70 8.90 6.85 6.43 4.47
Earnings Per Share(Adj)-Unit Curr 5.37 6.70 8.90 6.85 6.43 4.47
Book Value 118.44 91.09 74.50 63.04 54.35 47.95
Book Value(Adj)-Unit Curr 118.44 91.09 74.50 63.04 54.35 47.95

Shareholding Pattern

  • Promoter Group

    52.86%

  • Public Share Holding

    47.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,761,043 52.86 11,761,043 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,761,043 52.86 11,761,043 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,983,184 13.41 2,983,184 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,503,121 11.25 2,503,121 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,486,305 24.66 5,486,305 7
2] Non Institution
Bodies Corporate 1,150,358 5.17 1,150,358 55
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 95,288 0.43 95,288 130
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 145,800 0.66 145,800 193
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 901,187 4.05 901,187 20
Individuals holding nominal share capital up to Rs. 1 lakh 2,627,470 11.81 2,627,470 7,695
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2 0.00 2 1
Sub Total 5,002,562 22.48 5,002,562 8,104
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 22,249,910 100.00 22,249,910 8,115

Company Background

Sakar Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sakar Healthcare Ltd
  • BSE Code : 66415.0
  • ISIN : INE732S01012

  • Incorporation Year

    2004

  • Registered Office

    10/13 Nr MN Desai Petrol Pump
    Sarkhej Bavla Highway, Changodar,
    Gujarat-382213

  • Telephone

    91-2717-250477

  • FAX

    91-2717-251621

  • Chairman

    Sanjay S Shah.

  • Managing Director

    Sanjay S Shah.

  • Company Secretary

    Bharat Soni

  • Auditor

    J S Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Sakar Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sakar Healthcare 342.90 156.53 153.35 38.10 7.36
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10